| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/19/2006 | CN1805759A Uptake of macromolecules |
| 07/19/2006 | CN1805733A Absorption enhancers such as e.g. BHTíóBHA or propyl gallate |
| 07/19/2006 | CN1805731A Composition and device for enhancing dosing efficiency |
| 07/19/2006 | CN1803879A Soluble cross-linked polyvinyl alcohol polyurethane and synthesis method thereof |
| 07/19/2006 | CN1803870A PH sensitive solution polyacrylic acyloxy oxo acetate and its synthesis method |
| 07/19/2006 | CN1803868A Method for synthesizing soluble cross-linked polyvinyl alcohol dialdehyde |
| 07/19/2006 | CN1803142A Treatment and prophylaxis of diseases and infections of pigs and poultry |
| 07/19/2006 | CN1803141A Treatment and prophylaxis of diseases and infections of pigs and poultry |
| 07/19/2006 | CN1803140A Treatment and prophylaxis of diseases and infections of pigs and poultry |
| 07/19/2006 | CN1803134A Preparation method of magnetic nanometer granule containing mitocin-C |
| 07/19/2006 | CN1803133A Magnetic nanometer granule containing mitocin-C and its uses |
| 07/19/2006 | CN1264858C Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 07/19/2006 | CN1264833C Nonviscous protein type synthetic compound or its carrier combined compound |
| 07/19/2006 | CN1264578C Carrier with solid fibrinogen and solid thrombin |
| 07/19/2006 | CN1264575C PEG or polyethylene oxide-urate oxidase conjugates and use thereof |
| 07/19/2006 | CN1264574C Oral preparations |
| 07/19/2006 | CN1264514C Pediatric formulation of gatifloxacin |
| 07/19/2006 | CN1264504C Composition and preparation method of soft capsule shell colloid emulsion |
| 07/18/2006 | US7078552 Combretastatin A-1 phosphate and combretastatin B-1 phosphate prodrugs |
| 07/18/2006 | US7078526 Crystal structured fungicides selected from itraconazole, posaconazole or saperconazole used for prevention or prophylaxis of fungi, yeasts and dermatophyte infections |
| 07/18/2006 | US7078496 Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith |
| 07/18/2006 | US7078416 Polypeptides |
| 07/18/2006 | US7078399 Antiulcer agents; antiinflammatory agents; therapy for ear infections |
| 07/18/2006 | US7078392 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
| 07/18/2006 | US7078388 DNA vaccines for farm animals, in particular bovines and porcines |
| 07/18/2006 | US7078380 comprises vancomycin-type antibiotics; peptide antibiotics; membrane proteins; defensins; for inhibiting peptidoglycan biosynthesis |
| 07/18/2006 | US7078060 Contacting an area with a solution of atomically disordered, nanocrystalline metal, metal alloy or metal compound; drug delivery; microbiocides; bactericides; fungicides; anticarcinogenic, -tumor and -inflammatory agents; viricides |
| 07/18/2006 | US7078058 Corticosteroid-containing pharmaceutical composition |
| 07/18/2006 | US7078057 Heating with carrier; mixtur eof fine and coarse particle sizes |
| 07/18/2006 | US7078053 Ibuprofen composition |
| 07/18/2006 | US7078052 Enhanced absorption and bioavailability |
| 07/18/2006 | US7078051 Fatty ester food adjuvants; isomerization |
| 07/18/2006 | US7078020 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating |
| 07/18/2006 | US7078019 Heating a drug ester to vaporize; cooling to form condensation aerosol; drug delivery kit for dispensing thin coatings |
| 07/18/2006 | US7078018 Aerosol therapy; heating, vaporization, cooling, condensation; analgesics; alcoholism |
| 07/18/2006 | US7078017 Delivery of sedative-hypnotics through an inhalation route |
| 07/18/2006 | US7078015 Temperature activated gaseous liposomes; therapy drug delivery; accumulating in cancer and disease tissue |
| 07/18/2006 | US7078013 Pretargeting methods and compounds |
| 07/18/2006 | CA2533038A1 Method of treatment for improved bioavailability |
| 07/18/2006 | CA2195556C Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 07/13/2006 | WO2006074451A2 Targeted chimeric molecules for cancer therapy |
| 07/13/2006 | WO2006073772A1 Polyethylene glycol linked mc4r or mc3r agonist peptides |
| 07/13/2006 | WO2006073410A1 Compositions, methods and devices for preparing less painful botulinum toxin formulations |
| 07/13/2006 | WO2006073190A1 Composition for external use |
| 07/13/2006 | WO2006073164A1 Dialysis preparation |
| 07/13/2006 | WO2006073162A1 Method for improving storage stability of nadh or nadph or salt thereof |
| 07/13/2006 | WO2006073061A1 Novel core-shell structure |
| 07/13/2006 | WO2006072685A2 Method for preparing a solid pharmaceutical composition with prolonged and controlled release by high pressure treatment |
| 07/13/2006 | WO2006072243A1 Hyaluronic acid fraction with moisturizing and anti-wrinkle properties |
| 07/13/2006 | WO2006072202A1 A rantes-dt390 recombinant immunotoxin plasmid targeting activated th1 cells and production method and uses thereof |
| 07/13/2006 | WO2006050130A3 Glycan analysis using deuterated glucose |
| 07/13/2006 | WO2006038185A3 Use of the staudinger ligation in imaging and therapy end kits for imaging and therapy |
| 07/13/2006 | WO2006032977A3 Stabilized leukotriene b4 (ltb4) agent pharmaceutical |
| 07/13/2006 | WO2006026555A3 Neuroprotective effect of solubilized udca in focal ischemic model |
| 07/13/2006 | WO2006008003A3 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 1 (vpac1) |
| 07/13/2006 | WO2006006954A3 Modified fusion peptides derived from a p53 domain against malignant and/or transformed mammalian cells |
| 07/13/2006 | WO2006002195A3 Method of complexing a protein by the use of a dispersed system and proteins thereof |
| 07/13/2006 | WO2005123109A3 Pegylation of vasoactive intestinal peptide (vip)/pituitary adenylate cyclase activating peptide (pacap) receptor 2 (vpac2) agonists and methods of use |
| 07/13/2006 | WO2005113012A3 Beta adrenergic drug conjugated to bone targeting moiety for modulating bone mass |
| 07/13/2006 | WO2005102288A3 Lozenge for delivery of dextromethorphan |
| 07/13/2006 | WO2005067503A3 Confection product containing urea |
| 07/13/2006 | WO2004060300A3 Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity |
| 07/13/2006 | US20060155115 Multivalent T cell receptor complexes |
| 07/13/2006 | US20060155112 Plurality of peptide monomers each being attached at one end to a hub capable of interacting with a sub-unit of a self-assembling peptide to form an overlapping staggered structure or protein; purification of blood or biological fluids, cell assembly and tissue engineering |
| 07/13/2006 | US20060155101 Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
| 07/13/2006 | US20060155059 Polyethylene (glycol) derivatives with proximal reactive groups |
| 07/13/2006 | US20060154900 Diphosphonate solutions |
| 07/13/2006 | US20060154898 Diphosphonate solutions |
| 07/13/2006 | US20060154893 Exopolysaccharides delivery system for active molecules |
| 07/13/2006 | US20060154868 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/13/2006 | US20060154067 A hydrophilic, three-dimensional porous bead of open-cell lattice of a water-soluble polymer; intrusion volume of >3 ml/g.; produced by freeze-drying a droplet of the polymer in a continuous phase of an oil-in-water emulsion; uniform size distribution and shapes; carriers for cleaning, drugs et al |
| 07/13/2006 | US20060153931 Prevention of flap necrosis in plastic surgery |
| 07/13/2006 | US20060153930 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle |
| 07/13/2006 | US20060153908 Spherical pellet formulations |
| 07/13/2006 | US20060153906 Pharmaceutical product for endonasal administration for treating central nervous system disease and disorders |
| 07/13/2006 | US20060153905 Analgesic, Parkinson or Alzheimer drug in a solvent system containing a monoalkyl ether of diethylene glycol, a glycol, and a mixture of a C2 to C4 alcohol and water; inhibits crystallization and transfer to clothing, improves and modulates bioavailability within skin layers; nonocclusive, semi-solid |
| 07/13/2006 | US20060153903 Polymer sustainedly -release polymer amino acid derivative, cosmetic and fiber construct containing the polymer of producing the same and method for regenerating the same |
| 07/13/2006 | US20060153899 Palatinose for enhancing dietary supplement and pharmaceutical delivery |
| 07/13/2006 | US20060153898 Orally administering to a human subject in need thereof, just prior to nighttime sleep, from about 10 grams to about 250 grams of a muscle growth enhancing mixture, the mixture comprising:nutritional food proteins selected from milk proteins, whey protein, wheat protein, soy protein |
| 07/13/2006 | US20060153897 Zinc-containing foods |
| 07/13/2006 | US20060153885 Dry eye treatment |
| 07/13/2006 | US20060153859 Ganglioside-KLH conjugate vaccine with QS-21 |
| 07/13/2006 | US20060153839 Production of bispecific molecules using polyethylene glycol linkers |
| 07/13/2006 | US20060153801 Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| 07/13/2006 | US20060153795 Macromer having at least one NO carrying region or NO modulating compound which is released from the macromer; restenosis, thrombosis, asthma, wound healing, arthritis, penile erectile dysfunction |
| 07/13/2006 | US20060153791 Mixture of protein polymer and active materials |
| 07/13/2006 | US20060153779 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation |
| 07/13/2006 | US20060153776 Echogen microparticles essentially used as a contrast agent for ultrasound exploration and/or as emboli for ultrasound detection |
| 07/13/2006 | US20060151899 Process for producing drug ultramicroparticle and apparatus therefor |
| 07/13/2006 | DE102004062201A1 Urethanverbindung, die ein Polyethergruppen-haltiges Siliconderivat und einen Stickstoffheterocyclus eingebaut enthält Urethane compound that contains a built-in polyether-containing silicone derivative and a nitrogen heterocycle |
| 07/13/2006 | CA2744999A1 Regimens for intra-articular viscosupplementation |
| 07/13/2006 | CA2594332A1 Nanoparticulate candesartan formulations |
| 07/13/2006 | CA2594273A1 Method for preparing a solid pharmaceutical composition with prolonged and controlled release by high pressure treatment |
| 07/13/2006 | CA2593648A1 Targeted chimeric molecules for cancer therapy |
| 07/13/2006 | CA2592860A1 Hyaluronic acid fraction with moisturizing and anti-wrinkle properties |
| 07/13/2006 | CA2591138A1 Antibodies against antigen presenting cells and uses thereof |
| 07/13/2006 | CA2575248A1 Antibody vaccine conjugates and uses therefor |
| 07/12/2006 | EP1679085A2 Pressure-sensitive adhesive sheet for application to skin |
| 07/12/2006 | EP1679084A1 X-ray contrast medium containing liposome and method for preparation thereof |
| 07/12/2006 | EP1679080A2 Prevention and treatment of amyloidogenic disease |